Title: The anti-cancer and anti-inflammatory actions of 1,25(OH)(2)D(3)
Authors: Vanoirbeek, Els
Krishnan, A
Eelen, Guy
Verlinden, Lieve
Bouillon, Roger
Feldman, D
Verstuyf, Annemieke # ×
Issue Date: Aug-2011
Publisher: Bailliè€re Tindall
Series Title: Baillière's Best Practice & Research. Clinical Endocrinology and Metabolism vol:25 issue:4 pages:593-604
Abstract: Various epidemiological studies have shown an aetiological link between vitamin D deficiency and cancer incidence. The active metabolite of vitamin D, 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)], has potent anti-cancer activities both in vitro and in vivo. These anti-cancer effects are attained by regulating the transcription of numerous genes that are involved in different pathways to reduce tumorigenesis and are dependent on the cancer cell type. Besides reducing cell growth and inducing apoptosis, 1,25(OH)(2)D(3) also inhibits angiogenesis and metastasis. Moreover, its potency to inhibit inflammation also contributes to its anti-tumoral activity. Here, we report the different ways in which 1,25(OH)(2)D(3) interferes with the malignant processes that are activated in cancer cells.
ISSN: 1521-690X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical and Experimental Endocrinology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science